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ABSTRACT
Objective: The aim of the study was to investigate the use of a novel hyaluronic acid/polycaprolactone
material formeniscal tissue engineering and to evaluate the tissue regeneration after the augmentation of the
implant with expanded autologous chondrocytes. Two different surgical implantation techniques in a sheep
model were evaluated. Methods: Twenty-four skeletally mature sheep were treated with total medial me-
niscus replacements, while two meniscectomies served as empty controls. The animals were divided into two
groups: cell-free scaffold and scaffold seeded with autologous chondrocytes. Two different surgical tech-
niques were compared: in 12 animals, the implant was sutured to the capsule and to themeniscal ligament; in
the other 12 animals, also a transtibial fixation of the horns was used. The animals were euthanized after 4
months. The specimens were assessed by gross inspection and histology. Results: All implants showed ex-
cellent capsular ingrowth at the periphery.Macroscopically, no difference was observed between cell-seeded
and cell-free groups. Better implant appearance and integrity was observed in the group without transoss-
eous horns fixation. Using the latter implantation technique, lower joint degeneration was observed in the
cell-seeded group with respect to cell-free implants. The histological analysis indicated cellular infiltration
and vascularization throughout the implanted constructs. Cartilaginous tissue formation was significantly
more frequent in the cell-seeded constructs. Conclusion: The current study supports the potential of a novel
HYAFF/polycaprolactone scaffold for total meniscal substitution. Seeding of the scaffolds with autologous
chondrocytes provides some benefit in the extent of fibrocartilaginous tissue repair.
INTRODUCTION
LESIONS OF THE MENISCUS are frequently observed inorthopedic practice. Injury or loss of meniscal tissue
potentially leads to pain, knee dysfunction, and osteoar-
thritis at long term.1–3 Healing of ruptured menisci is
usually limited to the vascularized areas in the outer one-
third of the meniscus.4,5 Studies have demonstrated that
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healing of the knee is inversely related to the amount of
meniscal tissue resected.6,7 However, a large proportion
of meniscal tears observed at arthroscopy remain irrepara-
ble, and partial, subtotal, or even total meniscectomy is
often necessary, regardless of the recognized consequence.
In cases of extensive destruction and complete loss of the
meniscus, only two methods are available in clinical
practice today for meniscal substitution: allograft trans-
plantation and collagen meniscus implantation. In cases of
extensive destruction with a meniscal rim left intact, the
collagen meniscus implant (CMI) is used for partial me-
niscus substitution. Complete loss of the meniscus can only
be treated by allograft transplantation. In properly selected
patients, meniscal allografts based on various preservation
techniques (fresh, fresh frozen, and cryopreserved) have
been shown to heal to the capsule and relieve pain. How-
ever, their long-term success, durability, safety, and chon-
droprotective effects are still uncertain.8,9
The CMI (ReGen Biologics, Franklin Lakes, NJ) is
the only scaffold used so far in a clinical setting,10–14 even
if CMI cannot be considered as total meniscal substitute as
a residual rim of the original meniscus is necessary to fix
the implant. Despite improvements in pain and self-
evaluation,12 the histological and magnetic resonance ima-
ging (MRI) results remain controversial.10,13,15
Several materials have been tested as partial meniscus
substitutes in animal models. Veth et al.16 used carbon fiber
for meniscus repair in dogs, with unsatisfactory results.
Small intestinal submucosa (SIS) was successfully used to
repair posterior vascular meniscal defects,17 but not for
total substitution. Total meniscus substitution remains dif-
ficult and has been poorly described in the literature. A
polyvinyl alcohol–hydrogel meniscus in rabbits showed
promising results in terms of chondroprotection, but cer-
tain unresolved problems persisted, such as durability of
the polymer, the fixation method, and complete tissue re-
generation in a material that does not adhere to tissue.18,19
Tienen et al.20 applied two different porous polyester
urethane polymers as meniscus prostheses in dogs. Al-
though they also showed promising results in respect of
tissue formation, one of the materials (aromatic 4,4,-di-
phenylmethanediisocynate based) is thought to degrade
into toxic products. Other porous polymer implants did not
prevent cartilage degeneration or were not suitable as me-
niscal substitutes because of poor tissue ingrowth related to
polymer degradation rate, and poor mechanical proper-
ties.21–23
Tissue engineering has recently been proposed as a
possible solution for meniscal regeneration.15,24–28 There
have, however, been very few animal studies reported in
the literature that have investigated the possibility of using
cells in a partial or total meniscal substitute.15,24 Walsh
et al.25 used a collagenous sponge loaded with mesenchy-
mal stem cells to heal a partial meniscus defect in rabbits
and reported that the presence of cells augmented the repair
process but did not prevent degenerative osteoarthritis.
Martinek et al.15 reported better macroscopic and histo-
logical results in CMI implants seeded with meniscal fi-
brochondrocytes in comparison to cell-free implants in
sheep. However, the tissue-engineered meniscus was bio-
mechanically unstable and the implant size reduced during
the 3-month observation period. The authors suggested that
an improvement in scaffold and cell seeding procedure is
required before human application.
Different cell sources have also been analyzed in vitro
to find the most suitable source for cell augmentation of
tissue-engineered meniscus. Articular chondrocytes showed
the highest capacity for generating tissues with cellular and
matrix phenotypes including glycosaminoglycan expres-
sion similar to those of both the inner and outer meniscus
regions.29 Moreover, cartilage harvesting from a minorly
loaded joint area would be less damaging to the joint as
compared to healthy meniscal tissue harvesting. The sur-
gical technique used in animal models for total meniscal
replacement has also not been highly investigated and
consistent, as authors use different animal models (rabbit,
dog, and sheep) and diverse surgical techniques.
In a previous study, a new resorbable biomaterial con-
sisting of hyaluronic acid (HYAFF; Fidia Advanced Bio-
polymers [FAB], Abano Terme, Italy) and polycaprolactone
(PCL) was tested for total meniscal substitution in an in vivo
study in sheep. Tissue integration between the joint capsule
and the implant was observed with tissue formation, cellular
infiltration, and vascularization.30 Our hypothesis was that
the application of a tissue engineering approach, using cells
seeded onto this scaffold, would offer some benefits in pa-
tients submitted to total meniscectomy by increasing the
biological response and remodeling processes. Therefore,
the aim of the current study was to investigate the feasibility
of using this novel material for meniscal tissue engineering
and to evaluate the tissue regeneration after the augmenta-
tion of the implant with autologous articular chondrocytes
expanded ex vivo. The secondary aim was to evaluate two
different surgical scaffold implantation techniques in an
animal model: suture to the capsule and to the meniscal
ligament, with or without transtibial fixation of the horns.
MATERIALS AND METHODS
Study design
All procedures were approved by the Technical, Scien-
tific, and Ethics Committees of both experimentation cen-
ters (Rizzoli Orthopaedic Institute and Vienna University)
and by the Italian and Austrian Ministries of Health. The
study was performed by strictly following National Laws
on animal experiments (Law by Decree 116/92 and TVG,
BGBI No. 501/1988, 169/1999, and 136/2001).
Twenty-six skeletally mature female adult sheep, mean
age 3.1 years ( 1.8 years) (13 Bergamasca–Massese,
70 5 kg body weight [b.w.], and 13 Austrian Stone sheep,
1068 KON ET AL.
55 11 kg b.w.) were acquired from authorized farms,
and kept in quarantine for at least 7 days before use.
Under general anesthesia, animals underwent medial total
meniscal meniscectomy of the right stifle joint and were
divided into two groups. The cell-seeded group (n¼ 12)
received total medial meniscal replacement by the im-
plantation of a scaffold seeded with autologous chon-
drocytes, while in the cell-free group (n¼ 12), a meniscus
was replaced by a cell-free scaffold.
In each animal group (cell seeded and cell free), two dif-
ferent surgical techniques of scaffold implantation were
compared: in six animals of each group, the implant was
sutured to the capsule and to the meniscal ligament (R ani-
mals) (Fig. 1). In the other six animals of each group, the
implantation was performed in the same way, but also the
transtibial fixation of the horns was used (V animals) (Fig. 2).
In the cell-free group, the left stifle joints served as non-
operated joints for comparison. In the cell-seeded group, the
cartilage biopsy was performed from non-weight-bearing
areas of the left stifle joint to obtain the chondrocyte culture.
The medial meniscus was left untouched, and these joints
were used as sham controls in order to see the impact of
the arthrotomy in a healthy joint. The cells harvested from
the sheep were expanded and then seeded onto the scaffold
as described below. Each group had one empty control
(two animals) with total medial meniscectomy left un-
treated. In the empty controls, medial meniscectomy was
performed using the same surgical technique as described
above without insertion of a meniscus device.
All sheep received an external plaster (Scotch/Soft Cast;
3M Health Care, St. Paul, MN) to limit motion at the op-
erated limb for 5 days, as described by Dorotka et al.31 Free
movement within the cage was permitted immediately after
surgery. After 2 weeks, the stitches were removed and the
sheep were returned to the external stabling fields until the
end of the experiment (16 weeks).
Surgical procedure
Surgery was conducted under general anesthesia. General
anesthesia was performed following a standardized proto-
col: premedication with 10 mg/kg ketamine i.m. (Ketavet
100; Farmaceutici Gellini SpA, Aprilia, Latina, Italy),
0.3 mg/kg xylazine i.m. (Rompun Bayer AG, Leverkusen,
Germany), and 0.0125 mg/kg atropine sulfate s.c.; induction
with 6 mg/kg sodium thiopentone i.v. (2.5%); maintenance
with oxygen, NO2, and 2–3% fluothane (Halothan; Hoechst
AG, Frankfurt, Germany) under assisted ventilation (Servo
Ventilator 900 D; Siemens, Munich, Germany). A blood
analysis was performed from the radial vein. Antibiotics
(cefalosporin 1 g/day for 5 days) and analgesics (ketoprofen
500 mg/day for 3 days) were administrated postoperatively,
and a veterinarian checked the animals’ health.
An anteromedial arthrotomy was performed. The medial
collateral ligament (MCL) was cut slightly above the joint
line. This was necessary to achieve good exposure of the
posterior aspect of the joint. The meniscus was cir-
cumferentially dissected from the capsule; the posterior
horn of the meniscus was exposed by flexion, external ro-
tation, and valgus stress of the joint; the meniscus was
detached at its posterior and anterior horns. No residual
meniscal rim was left. In 12 sheep (6 cell freeþ 6 cell
seeded), the implant was sutured to the capsule at the level
of the original meniscal rim, the anterior and posterior
horns of the implant being fixed to the meniscal ligaments
(R group, Fig. 1). In the other 12 sheep (6 cell freeþ 6 cell
seeded), the implantation was performed in the same way,
but, additionally, two 3-mm tunnels were drilled with a
guide wire from the medial tibial condyle to the footprints
of the anterior and posterior meniscal horns. Two non-
resorbable anchoring sutures were inserted through the
implant at its horns, pulled through the bone tunnels, and
tied to each other in a knot on the tibial surface (V group,
Fig. 2). The capsule was closed. The MCL was recon-
structed with four sutures, using resorbable sutures. The
skin was closed by standard surgical techniques.
FIG. 1. Surgical technique used in R group of animals: implant
was sutured to the capsule, the anterior and posterior horns of the
implant being fixed to the meniscal ligaments.
TISSUE ENGINEERING FOR MENISCAL SUBSTITUTION 1069
Biomaterial and implant
Porous scaffold preparation. The scaffold was a porous
blend of polycaprolactone (PCL) and HYAFF, a class
of hyaluronan-derived polymers obtained by a coupling
reaction (FAB), with a pore size of 200–300 mm. The
meniscus-like composite devices were produced by a
lamination technique using molds that were designed ac-
cording to original sheep menisci. Polycaprolactone (PCL)
pellets of 294 mg/mL (Mw¼ 65,000; Aldrich, St. Louis, MO)
were dissolved in a tetrahydrofuran/dimethyl sulfoxide 80/
20 (w/w) solution, by stirring the components at 458C. A
mixture of salts consisting of 93.9% (w/w) sodium chloride
(with granulometry 315–400 mm), 3.5% (w/w) sodium
bicarbonate (with granulometry 140–315 mm), and 2.6%
(w/w) citric acid (with granulometry inferior to 200 mm)
was prepared. Successively, PCL solution and HYAFF-11
p75 HE powder (supported by FAB) at a ratio of PCL/
HYAFF 70/30 (w/w) were mixed with salts, until a homo-
geneous paste was obtained. The ratio of polymers to salts
was 1/10. The salts increase the porosity of the structure
and ensure the interconnection of pores.
The paste obtained was then poured in a meniscus-
shaped Teflon mold containing a polylactic acid (PLA) net.
The meniscus device was augmented with circumferential
PLA fibers, which protruded at the anterior and posterior
horns and could be pulled through transosseous tunnels.
PLA fibers were arranged in the mold, and the remaining
paste was used as matrix to fill it. The samples obtained
were left in air for 24 h and immersed in bidistilled water
for 1 day. Subsequently, they were immersed in bidistilled
water at 408C for 5 h to remove the solvents. The porous
scaffolds were then left in bidistilled water for a further 5
days, changing the water everyday for complete removal of
salts and any residual solvents. The samples were removed
from molds and immersed in an ethanol/water 70/30 (w/w)
solution, followed by placement in an Edwards lyophili-
sator to remove the water. The porous scaffolds obtained
were immersed in a 8 mg/mL hyaluronic acid solution and
lyophilized again. The structures were finally sterilized
through g radiation (2.5 Mrad). The length of the final
implants was 32 mm, and the diameter was 22 mm. The
height of the implant at the periphery was 6 to 8 mm.
The final implants were analyzed by scanning electron
microscopy (Leica, Solms, Germany), microtomography
(SkyScan, Kontich, Belgium), and microCT.
The in vivo degradation time can be estimated on the
basis of the behavior of the individual components. PCL
degrades slowly by hydrolytic chain scission of the ester
linkage.32 PCL loses its in vivo molecular weight slowly
(up to 12 months, depending on the polymer composition),
but loses its mechanical stability much earlier (between 12
and 16 weeks).33 HYAFF-11 degrades by deesterification
in 3–4 months in vivo.34
Implant assessment
Porous scaffolds were cut along the cross section and
subjected to analysis for evaluating the pore average size by a
scanning electron microscope (Leica, 420). The material in-
vestigated was characterized by highly interconnected pores
with an average pore size of 250mm (Fig. 3A, B). Moreover,
the porous scaffolds displayed a large surface area, which
should support cell attachment and tissue ingrowth.
Porous scaffolds, sheep medial menisci, and meniscus
devices prepared were analyzed by a SkScan microtomo-
graph allowing a spatial resolution of 5 mm corresponding
to near 1107 cubic mm voxel size, making a nonde-
structive three-dimensional (3D) reconstruction of the po-
rous samples inner structure from two-dimensional X-ray
shadow projections (Fig. 3C, D). Several parameters ob-
tained from the microtomographic analysis, including total
volume (Vtot), specific volume (n), empty index (e), and
porosity (P), were evaluated through CTAn software. The
results are shown in Table 1.
FIG. 2. Surgical technique used in V group of animals: implant
was sutured to the capsule, the anterior and posterior horns of the
implant fixed with nonresorbable anchoring transtibial sutures.
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MicroCT analysis was also undertaken to perform 3D
reconstructions of sheep medial meniscus (Fig. 4A). Using
data from these 3D reconstructions and Materialise
MIMICS software, 3D CAD drawings have been designed
and used to produce the appropriate molds (Fig. 4B).
Cell–scaffold construct preparation
Cartilage biopsies were taken from the left stifle joints.
An anteromedial arthrotomy was performed, and cartilage
was harvested from the non-weight-bearing areas of the
trochlea. The cartilage biopsies were put into sterile 50 mL
tubes with nutrient medium and sent to FAB for the
cell seeding procedure. Chondrocytes were isolated by se-
quential enzymatic digestions. Cartilage was incubated for
30 min with 0.1% hyaluronidase (Sigma, St. Louis, MO),
1 h with 0.5% pronase (Sigma), and 1 h with 0.2% colla-
genase (Sigma) at 378C. The isolated chondrocytes were
then centrifuged for 10 min at 1800 rpm, and the pellet
was washed twice with Dulbecco’s modified Eagle’s me-
dium (DMEM) supplemented with 10% fetal calf serum
(FCS; Sigma). The cells were cultured under conventional
monolayer culture conditions at 378C in 5% carbon diox-
ide. The medium was changed every 3–4 days. After the
third to fourth passage, chondrocytes had uniformly ac-
quired a fibroblastic, dedifferentiated morphology and were
then dynamically seeded onto the meniscus prototype at a
density of 25106 cells/cm3 (i.e., 40106 cells/scaffold) in
a mixed flask (50 rpm) in a volume of 100 mL of DMEM,
supplemented with 10% FCS (complete medium) (Fig. 5).
Medium was removed 24 h after seeding and replaced by
complete medium supplemented with 10 mg/mL insulin,
0.1 mM ascorbic acid, and 1 ng/mL transforming growth
factor beta 1 (TGFb1). Media were changed twice a week
thereafter. After 14 days of spinner flask culture, prototypes
were ready for in vivo implantation.
Evaluation
Specimen preparation and gross inspection. Sixteen
weeks after surgery, the sheep were euthanized under
general anesthesia by endovenous administration of Tanax
(Hoechst, Frankfurt am Main, Germany). A sample of
FIG. 3. Images of porous structure obtained through scanning electron microscopy analysis (A, B) and with microtomograph Skyscan
1072 (C, D).
TABLE 1. VALUES OF PARAMETERS OBTAINED THROUGH
TOMOGRAPHIC ANALYSIS PERFORMED ON POROUS SCAFFOLDS
Vtot (mm
3) 22.36
Vs (mm
3) 7.12
Vv (mm
3) 15.24
n 3.14
e 2.14
P 0.68
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blood was taken for analysis to detect infection or allergic
reactions. A radiographic examination was performed, and
the joints were assessed clinically for swelling and stability.
The clinical examination of ligament stability was per-
formed under anesthesia in comparison to the contralateral
joint before the resection of the joint. Under sterile condi-
tions, the right and the left joints were opened through the
previous approach, a swab for microbiological analysis and
a synovial aspirate were taken, and the presence of effusion
or popliteal cysts was documented. Synovial fluid was ana-
lyzed for the presence of inflammatory cells.
The joint was resected in toto, and the restoration of the
MCL was inspected. Joint status was assessed using the
Gross Assessment of Joint Changes Score published by
Jackson et al.,35 which scores 12 different areas of the joint,
including the femoral and tibial cartilage, the patella, its
femoral groove, the menisci, and the femoral junction. A
Gross Evaluation of Meniscus Implant Score was used
to assess implant outcome.30 This includes nine different
categories: implant size, implant integration, implant po-
sition, horn position, implant shape, presence of tears, im-
plant surface, tissue quality, and condition of the synovia.
In this system, the minimum total score is 9, indicating an
excellent outcome, and the maximum total score is 27
points. The specimens were photographed, and then the
implant was dissected from the tibia.
Histological evaluation. The meniscal implants were cut
into an anterior part and a posterior part at the level of the
MCL. Consecutive 3-mm slices (inner to outer) were cut to
produce blocks allowing histological sections that showed
inner and outer regions, superior and inferior surfaces of the
potentially regenerated meniscus, and attachment to the
joint capsule. Of each implant, two central and two pe-
ripheral blocks were evaluated. A synovial biopsy from the
medial compartment adjacent to the meniscal implant was
taken from each joint. Tissue blocks were fixed in 10%
neutral-buffered formalin and processed into paraffin wax.
Paraffin sections were cut at 3–4 mm and stained with (i)
hematoxylin and eosin for assessment of cellular features,
(ii) alcoholic toluidine blue for assessment of glycosami-
noglycan content, and (iii) picro-sirius red for assessment
of collagen deposition.
Sections were blindly evaluated by an experienced os-
teoarticular pathologist (D.M.S.). Blocks of synovium were
assessed for the presence of synovial cell hyperplasia/
hypertrophy and an inflammatory cell infiltrate. Blocks of
meniscal implant were assessed for the presence of residual
scaffold, cellularity, foreign body response, inflammatory
cell (lymphocytes, plasma cells, and neutrophils) infiltrate,
blood vessel ingrowth, fibrous and cartilaginous matrix, and
integration of the implant with the joint capsule. Cartila-
ginous matrix was identified as being present if cells in an
area of tissue had a spherical/chondroid appearance and the
surrounding matrix showed metachromasia in alcoholic
toluidine blue–stained sections. Integration was scored as
being good if there was no discontinuity between the im-
plant and original joint capsule. Histological features were
scored as being either present or absent.
For assessment of chondroprotective effects of the
scaffold, sections were cut from formalin-fixed and paraf-
fin-embedded transverse blocks through central, anterior,
and posterior parts of the tibial plateau and femoral con-
dyle. Sections were stained with hematoxylin and eosin
and alcoholic toluidine blue, and scored blindly by D.M.S.
using a modified Mankin grading system—Structure: Intact
surface 0, Surface fissures 1, Surface fissures to mid zone 2,
Surface fissures to deep zone 3, Complete loss of articular
cartilage 4; Cells: Normal 0, Some hypercellularity 1,
Clusters/cloning 2, Hypocellularity 3, Complete loss of
articular cartilage 4; Proteoglycan staining: Normal 0,
Slight reduction 1, Moderate reduction 2, Severe reduction
3, No dye noted 4. Scores from each of the blocks from a
tibial plateau or femoral condyle were averaged to provide
a score for that joint. The results shown are the mean SD
of the average score for each group.
Statistical analysis
Statistical analysis was performed using the SPSS v.12.1
software (SPSS, Chicago, IL). Assessments were made in
the absence of knowledge of whether implants were seeded
or unseeded. Subsequently, results were tabulated against
the nature of the implant, that is, seeded or unseeded in
both R and V groups (Student’s t test). Univariate ANOVA
with Tukey’s post hoc test was used to compare data among
all groups. Data were considered significant with p< 0.05.
RESULTS
Engineered graft characterization
Stirring of the cell suspension in the mixed flask, where
the meniscus-shaped scaffold was fixed, resulted in a cell
distribution predominantly at the edges and at the periphery
FIG. 4. 3D reconstructions of a sheep medial meniscus (A, top)
and of medial meniscus device (B, bottom).
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of the scaffold as assessed by MTT staining 1 day after the
beginning of cell seeding (Fig. 3). After a total of 14 days
of culture, cells and extracellular matrix were still confined
at the scaffold surface (Fig. 5). Sulfated glycosaminogly-
cans (GAG) staining was not evident in the extracellular
matrix that had accumulated after 14 days. This was in
agreement with low measured GAG amounts (average
GAG/DNA: 4.5 0.9 mg/mg) and may be explained by the
relatively low initial density of cells achieved after seeding.
Clinical assessment
All animals tolerated surgery well and survived the
postsurgical period. When dissecting the knees, one animal
belonging to the R group (cell seeded, R13) showed signs
of severe osteoarthritis in both implanted and contralateral
sham control knee. Therefore, this sheep was excluded
from the postexplant evaluation. For the remaining sheep,
gait was normal without limp. All joints were stable. No
differences in gait and joint stability were found between
left nonoperated limbs and the limbs where cartilage har-
vesting was performed (sham controls).
All sheep showed soft tissue swelling on the medial as-
pect of the operated joints. A mild effusion in the form of
a clear synovial fluid was detected in nine joints (four
cell free, three cell seeded, one sham control, and one
nonoperated control). There were no signs of synovitis.
Comparison of postoperative and preoperative radiographs
revealed no signs of fracture.
Implant gross assessment
The results are summarized in Table 2A and B. Better
evaluation scores were observed in R group respect to V
group, where transosseous sutures were used but no sig-
nificant differences were detected among groups. While
pooling data of R and V sheep, no statistically significant
difference was observed between cell-seeded and cell-free
groups: the mean meniscus score was 20 (cell seeded and
cell free).
Figures 6 and 7 illustrate macroscopic appearance of
meniscal implant in different groups. All implants showed
excellent capsular ingrowth at the periphery. In fact, the
integration was complete in 11 cases, and partial in the
others. The implant was dislocated in five cases (two cell
free and three cell seeded). All dislocations were noted in
the V group where the transtibial fixation of the horns was
used. The anterior horns were anatomically positioned and
firmly attached in all cases except for two joints. A slight
extrusion of the implants at the periphery and wrinkling in
the posterior region were frequently observed, probably
causing mechanical problems and the detachment of the
horns in the posterior aspect of the joint space, especially
FIG. 6. Macroscopic appearance of meniscal implant in cell-
free group.
FIG. 5. (A) Seeding and culture of sheep articular chondrocytes in a meniscus-shaped brain factor 1 (BF-1) scaffold in a mixed flask
under continuous stirring. (B) MTT staining after 1 day of culture in the mixed flask. The top picture is a view of the top surface of the
scaffold, and the bottom picture is a representative cross section. Violet dots correspond to areas stained with MTT and indicate the
presence of metabolically active cells. (C) Safranin-O staining of a construct cross section after 14 days of culture in mixed flask. Scaffold
network is strongly stained in dark red, whereas the formed tissue, predominantly present at the scaffold edges, is negatively stained.
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when the transtibial fixation was used. The menisci proto-
types had maintained the meniscus-like or mixed shape
in 21 cases; in 3 cases implants were out of shape. Ten
implants (four cell free and six cell seeded) had a full-
substance tear. Nine of those were observed in the V group.
The surface of the biomaterial in all cases was completely
covered with a shiny, smooth synovium-like tissue, which
showed signs of blood vessel formation. Slightly hyperemic
synovium was observed in the majority of the cases. No
synovial hypertrophy or fibrosis was noted.
Joint gross assessment
The results are summarized in Table 3A and B. The
meniscectomy controls showed a score of 14 and 13, re-
spectively. Joint degeneration in the nonoperated joints
(mean score: 1.2) and in sham controls (mean score: 1.1)
was negligible. No statistically significant difference was
noted between cell-seeded (5.8) and cell-free (8.0) groups
when data were pooled. There was, however, significantly
lower joint degeneration observed in R group cell-seeded
implants as compared to R group cell-free implants
( p< 0.01).
In the operated joints, the reconstruction of the MCL had
healed in all cases. Variable degrees of cartilage damage
were observed in the operated joints (min 2 and max 13).
The score of sheep R13 was 18 in the operated knee and 7
in the sham-operated knee, confirming the presence of
spontaneous osteoarthritis development and supporting the
exclusion of this animal from the histological evaluation.
The subchondral bone was exposed in four cases of cell-
free group and in one sheep of cell-seeded group. The
thickness of the medial joint capsule was noted in all op-
erated joints where the MCL resuturing was performed.
Histological evaluation
There was no evidence of a significant inflammatory cell
infiltrate in the synovium of joints that contained either
cell-seeded or cell-free implants.
The results of the histological assessment of the meniscal
implants are summarized in Table 4. Residual scaffold with
an associated foreign body response consisting of a mixed
giant cell and mononuclear histiocyte infiltrate was pres-
ent in all the implants. In general, the foreign body reac-
tion was florid, but focally in some of the implants, areas of
TABLE 2A. GROSS EVALUATION OF THE MENISCUS IMPLANT SCORE IN R ANIMALS (MIN. 9–MAX. 24 POINTS)
Cell free Cell seeded
R23 R9 R10 R11 R12 R14 R24 R25 R26 R27 R28
Integration 3 3 2 3 2 3 2 2 3 2 3
Implant position 2 3 3 3 2 2 2 2 3 2 3
Horn position 2 3 2 3 2 3 2 2 3 2 3
Shape 2 3 2 3 2 3 2 2 3 2 2
Tears 2 3 2 2 1 3 2 2 3 2 3
Surface 3 3 3 3 3 3 3 3 3 3 3
Size 3 3 3 3 2 3 2 2 3 2 3
Tissue 2 2 2 2 2 2 1 1 2 1 2
Synovia 2 3 2 3 3 3 1 2 2 2 3
Total score 21 26 21 25 19 25 17 18 25 18 25
Mean score SD 20.7 3.6 23.2 3.0
TABLE 2B. GROSS EVALUATION OF THE MENISCUS IMPLANT SCORE IN V ANIMALS (MIN. 9–MAX. 27 POINTS)
Cell free Cell seeded
V6 V13 V21 V36 V41 V45 V1 V2 V17 V35 V38 V39
Integration 3 3 2 2 3 2 2 2 2 2 3 3
Implant position 2 2 1 2 3 1 1 2 1 1 2 2
Horn position 3 3 2 1 3 2 2 3 1 2 3 3
Shape 3 2 1 2 2 2 2 2 1 2 2 1
Tears 3 2 1 1 1 1 1 1 1 1 2 1
Surface 3 3 3 3 3 3 3 3 3 3 3 3
Size 2 3 2 3 3 3 2 2 2 3 3 2
Tissue 1 2 1 1 1 1 1 1 1 1 1 1
Synovia 3 3 2 2 2 2 2 2 3 2 2 2
Total 23 23 15 17 21 17 16 18 15 17 21 18
Mean SD 19.3 3.4 17.5 2.1
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hypocellularity were evident. In addition to the foreign
body reaction, all implants showed extensive vasculariza-
tion with an admixture of blood vessels including small
muscular arteries. Cellular tissue (Fig. 8A) was present
in all of the implants to a degree that varied from area to
area in the implant and did not appear to be related to cell
seeding. In contrast, small foci of cartilaginous differenti-
ation (Fig. 8B) were significantly more commonly seen in
the cell-seeded constructs ( p< 0.001). These foci of car-
tilage differentiation were present predominantly within
fibrous tissue covering the tip of the implants, and weak
metachromatic staining of tissue centrally within the im-
plants was seen in only two of the cell-seeded implants and
one unseeded implant. Scattered, small numbers of lym-
phocytes and plasma cells were present in both cell-seeded
and unseeded implants with no statistically significant dif-
ference. Small numbers of neutrophils were seen in only
two implants, one seeded and the other unseeded.
All the implants were covered by a smooth-surfaced fi-
brovascular tissue of variable thickness, which was in con-
tinuity with the adjacent capsule/synovium. This surface
tissue appeared to be contributing to the macroscopically
assessed integration in all of the implants. Histologically,
however, there appeared to be differences in the integration
of the cell-seeded and unseeded implants with the capsule. In
all 12 cell-free implants, there was an apparently tight in-
tegration between the implant and the capsule (Fig. 8C).
However, similar appearances were only seen in seven of the
cell-seeded implants. In the other five cases, the cell-seeded
implants showed a split in the tissue section along the line
FIG. 7. Macroscopic appearance of meniscal implant in cell-
seeded group.
FIG. 8. Histological features of meniscus implants. A prominent foreign body reaction to residual scaffold was present in all cases.
(A) HandE-stained section, 40. Foci of cartilaginous metaplasia as demonstrated by metachromatic staining were identified pre-
dominantly at the tips of implants. (B) Alcoholic toluidine blue–stained section,20. Integration with the joint capsule was identified as
being either good (C) or poor (D) as identified by the absence or presence of splits in the tissue between implant and host capsule. (C, D)
HandE-stained sections,5.
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where the implant met the capsule (Fig. 8D), or, in some
instances, a flattened cystic-like space was present.
Mankin scores
The results are shown in Table 5. The articular cartilage
in each of the groups of sheep showed evidence of osteo-
arthritic changes. In general, the histological changes of
osteoarthritis were more severe on the tibial plateau than on
the femoral condyles for both the R group and the V group.
There was no significant difference in the Mankin scores
when cell-seeded and non-cell-seeded implants were
compared in either group. Mankin scores in treated sheep
were not better than those of control sheep (tibial plateaux
4.5þ 1.44; femoral condyles 3.8þ 1.9).
DISCUSSION
Experimental studies concerning synthetic devices made
of polyurethane,36,37 polytetrafluoroethylene,38 and polyes-
ter carbon39 as possible alternatives to meniscus allografts
have yielded unsatisfactory results in terms of biocompati-
bility, material properties, and chondroprotection. In a dog
model, the resorbable bovine collagen scaffold developed
by Stone et al.40 for regeneration of meniscal tissue showed
host tissue ingrowth and formation of fibrocartilage resem-
bling a normal canine meniscus after 9 and 12 months.12 A
clinical trial concerning CMI revealed encouraging re-
sults,10,11,13,14 but long-term, histological and MRI results
are controversial and evidence of chondroprotection is still
pending. In contrast to the present study, the CMI is used for
partial meniscal substitution because a residual rim of the
original meniscus is necessary to fix the CMI, which makes
the comparison of our results difficult.
In the current study, we have investigated the feasibil-
ity of using a new resorbable biomaterial consisting of
TABLE 3A. GROSS ASSESSMENT OF JOINT CHANGES SCORE IN R ANIMALS (MIN. 48–MAX. 0 POINTS)
Cell free Cell seeded
Sheep Implanted knee Nonoperated knee Sheep Implanted knee Sham-operated knee
R23 11 1 R9 3 0
R24 10 2 R10 4 1
R25 11 3 R11 2 0
R26 7 1 R12 6 1
R27 13 2 R14 6 1
R28 4 1
Mean SD 9.3 3.2 1.6 0.8 4.2 1.7 0.6 0.5
TABLE 3B. GROSS ASSESSMENT OF JOINT CHANGES SCORE IN V ANIMALS (MIN. 48–MAX. 0 POINTS)
Cell free Cell seeded
Sheep Implanted knee Nonoperated knee Sheep Implanted knee Sham-operated knee
V6 6 3 V1 7 1
V13 6 0 V2 9 1
V21 9 0 V17 8 0
V36 8 0 V35 9 3
V41 6 2 V38 7 3
V45 6 0 V39 5 1
Mean SD 6.8 1.3 0.8 1.3 7.5 1.5 1.2 1.2
TABLE 4. HISTOLOGICAL FEATURES OF IMPLANTS
Implant
Cell free Cell seeded
Total V R Total V R
Residual scaffold 12 6 6 11 6 5
Foreign body reaction 12 6 6 11 6 5
Hypocellular areas 10 4 6 9 4 5
Blood vessels 12 6 6 11 6 5
Fibrosis 12 6 6 11 6 5
Cartilage metaplasia
Tip 1 1 0 8 4 4
Central 2 0 2 1 1 0
Integration
Good 12 6 6 7 5 2
Poor 0 0 0 5 1 4
Inflammatory infiltrate
Lymphocytes 9 3 6 10 5 5
Plasma cells 5 0 5 7 2 5
Neutrophils 1 1 0 1 1 0
The table shows the number of implants with each of the described
histological features. V: Vienese sheep; R: Rizolli sheep.
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hyaluronic acid and polycaprolactone for total meniscal
substitution in a sheep model with two different surgical
scaffold implantation techniques. Previously, we tested the
feasibility of hyaluronic acid and polycaprolactone (PCL)
scaffold for total meniscal replacement.30 We also explored
whether seeding the scaffold with autologous articular
chondrocytes was beneficial for meniscal regeneration.
Promising results were obtained by culturing autologous
and allogenic chondrocytes on a Vycril mesh scaffold in the
treatment of meniscal tears in pigs.24,27 Therefore, the aim
of the study was to assess whether there was an advantage
to using chondrocyte-seeded scaffolds. Autologous chon-
drocytes were used as we have previously demonstrated
that, both in vitro and following ectopic implantation, ex-
panded articular chondrocytes were superior to meniscal
cells, synovial cells, or fat pad cells in their capacity to
reach phenotypes typical of the inner and outer meniscus
regions.29 Moreover, it has recently been established that
the phenotype of articular chondrocytes may adapt upon
exposure to specific regimes of physical forces, thereby
generating tissue structures resembling some aspects of the
complex structure and function of native meniscus.41 The
choice was also influenced by the fact that harvesting
articular cartilage from a minorly loaded joint area would
be less damaging than harvesting part of healthy menis-
cus or little meniscal tissue probably remained after me-
niscectomy. Destroyed meniscus tissue that is removed
during resection cannot be considered a healthy tissue for
cell isolation.
Different fixation techniques are used for total and partial
meniscal transplantation in clinical practice. For total al-
lograft transplantation, rigid horn fixation with bone blocks
is usually used, even if some authors have proposed less
rigid and more physiological suturing technique.42 Al-
though the issue of the fixation technique in humans is
extensively studied,43 there are no studies comparing dif-
ferent techniques in animal model. In sheep models, the
meniscus transplant horns are generally fixed with trans-
osseous sutures.9,15,20,21,23 Considering that most of the
animal studies reports high incidence of implant lesions at
longer follow-up,9,15,23 we have decided to compare two
different implant fixation techniques to determine a most
suitable animal model for total meniscal substitution. The
degree of damage seen in the meniscal implants at the
completion of our study appears related to the implant
fixation technique used. We have used two different fixa-
tion techniques allowing comparison between transtibial
horn fixation with less rigid and more physiological fixation
to the joint capsule. The general joint stability was not
compromised in both groups. A higher incidence of tears
and implant dislocations and worse implant and joint ap-
pearances was observed in cases where transtibial, rigid
fixation of the horns was utilized (V animal group). It is
likely that a too rigid horn fixation in this weight-bearing
large animal model does not allow for physiological
movement of the meniscal horn, and resulted in overly high
mechanical stresses on the implant leading to a higher in-
cidence of graft tears. Similar results were reported by
Kelly et al.,9 who observed complete radial tears in all
meniscal implants with rigid horn fixation at 12-month
follow-up. This can be not predictable to utilize in humans,
but it appears likely that the less-rigid fixation technique is
preferable for total meniscal substitution in a sheep model.
A high incidence of implant tears and clefts, especially in
cases with a transtibial rigid fixation of the horns, was
detected, indicating that the mechanical properties of the
scaffold were probably not sufficient in the current model.
As such, the biomechanical properties of the material need
to be improved for future experimentation, possibly by
insertion of a stronger resorbable net inside the scaffold.
Whether similar problems encountered in this sheep model,
such as implant tears, would be encountered in the human
clinical setting is less clear. Although sheep were im-
mobilized in cast, full weight bearing cannot be completely
avoided in a sheep model,44 whereas controlled rehabili-
tation with limited weight bearing and range of motion in
humans may reduce these problems.
The implants appeared to be well tolerated immunologi-
cally by the sheep with no evidence macroscopically or
microscopically of a significant synovitis or lympho-
plasmacytic infiltrate. There was, however, a prominent
foreign body giant cell response to the implant, presumably
part of the physiological resorption process,34,45 which was
similar in cell-seeded and cell-free constructs. Reaction to
foreign material may be nonimmune or elicit an immune
response with memory. The intense, predominantly mac-
rophage and giant cell infiltrate into the scaffolds used in the
current study is suggestive of a foreign body response
without an immune component. However, it has been shown
recently that the extent of cellular infiltration may not be an
indicator of a potentially important immunological re-
sponse. Porcine small intestinal submucosa (SIS) has been
used as a scaffold for the treatment of large meniscal defects
in dogs with some degree of promise.17 Histological eval-
uation shows little evidence of an inflammatory cell infil-
trate in association with SIS scaffolds 12 weeks to 1 year
following implantation. Although this may suggest a lack of
an immunological response, it is becoming clear that SIS
graft recipients do amount a helper T type 2–restricted im-
mune response.46 Nevertheless, this is not associated with
graft rejection. In the case of SIS, the most likely cause of
TABLE 5. MANKIN SCORES
V group R group
Tibial
plateaux
Femoral
condyles
Tibial
plateaux
Femoral
condyles
Cell free 7.0þ 1.0 3.2þ 1.2 5.7þ 2.4 3.8þ 1.1
Cell seeded 6.9þ 1.0 3.8þ 1.2 6.3þ 3.4 3.7þ 2.9
Results are given as mean SD.
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this immune response is the presence of trace amounts of
porcine DNA.47 Although xenogeneic material is not used in
the current study and infiltration of the scaffolds by lym-
phocytes and plasma cells is limited, the possibility of an
immunological response that may contribute to graft de-
struction cannot be excluded.
Histological analysis of the implant material confirmed
the gross findings of tissue formation within and upon the
implant with bonding to the capsule. The tissue ingrowth
consisted of a fibrovascular connective tissue with a foreign
body response to the implant material. Collagen appeared
as a fine fibrillar network without orientation. Blood vessels
were present throughout the implants without suggestion of
formation of vascular and avascular areas as might be ex-
pected in normal menisci. Our findings are similar to those
achieved with 3-month samples of the CMI dog model,
where immature vascular connective tissue with fibroblasts,
numerous capillaries, and a fine fibrillar matrix were
seen.12 The impact of the giant cell reaction is difficult to
estimate. Neither the synovial biopsies nor the smears re-
vealed acute inflammatory cells.
Although no significant difference was shown between
cell-seeded and cell-free implants at 4-month follow-up
macroscopically, histological analysis did demonstrate de-
position of a cartilaginous matrix only in cell-seeded im-
plants, which may become more evident following longer
observation. As the matrix is seen predominantly in the
cell-seeded constructs, it is likely that the implanted cells
are involved in its production. Moreover, the distribution of
the cartilaginous matrix at the edges and the tip of the
implant is directly related to the distribution of cells and
matrix in the scaffold at the time of grafting. In this regard,
more homogenous and efficient seeding of the inner two-
thirds of the scaffold could probably improve the overall
mechanical and biological properties of the implant.
The current study supports the idea that a novel
hyaluronic-acid-polycaprolactone (HA-PCL) scaffold has
the potential for total meniscal substitution as it is not re-
jected and induces tissue ingrowth. There are, however,
some limitations with regard to the biological and me-
chanical properties of the scaffold. Less rigid and more
physiologic fixation technique of total meniscus implant is
considered preferable in sheep model and recommended for
further animal studies. Seeding of the scaffolds with au-
tologous articular chondrocytes provides some benefit with
more fibrocartilaginous tissue being produced also at early
stages of regeneration (4 months). Significant amounts of
scaffold remain at 4 months associated with a foreign body
reaction. It might be expected that a foreign body reaction
would last as long as there is a foreign (scaffold) material
present. In the presence of a brisk foreign body reaction, it
is more likely that a reparative fibrous tissue will arise
rather than a situation where committed tissue differentia-
tion is seen. Follow-up of at least a year in animal model
would appear to be necessary to assess how long the bio-
material remains in the tissue and to what extent a foreign
body inflammatory or immune response is present.
Longer-term animal studies are necessary to fully eval-
uate how long the scaffold material remains in situ and
whether this aids or delays meniscus tissue regeneration.
These further studies will also provide additional infor-
mation on the role of cell augmentation in promoting fi-
brocartilaginous tissue regeneration in complete meniscal
substitution.
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